| Overexpression of the RON gene in human breast carcinoma P Maggiora, S Marchio, MC Stella, M Giai, A Belfiore, MD Bortoli, ... Oncogene 16 (22), 2927-2933, 1998 | 268 | 1998 |
| Angiopoietin‐2 expression in breast cancer correlates with lymph node invasion and short survival C Sfiligoi, A de Luca, I Cascone, V Sorbello, L Fuso, R Ponzone, N Biglia, ... International journal of cancer 103 (4), 466-474, 2003 | 263 | 2003 |
| Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. C Dati, S Antoniotti, D Taverna, I Perroteau, M De Bortoli Oncogene 5 (7), 1001-1006, 1990 | 217 | 1990 |
| Estrogen receptor α controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs L Cicatiello, M Mutarelli, OMV Grober, O Paris, L Ferraro, M Ravo, ... The American journal of pathology 176 (5), 2113-2130, 2010 | 192 | 2010 |
| miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1 D Cimino, C De Pittà, F Orso, M Zampini, S Casara, E Penna, E Quaglino, ... The FASEB Journal 27 (3), 1223-1235, 2013 | 156 | 2013 |
| CircuitsDB: a database of mixed microRNA/transcription factor feed-forward regulatory circuits in human and mouse O Friard, A Re, D Taverna, M De Bortoli, D Corá BMC bioinformatics 11, 1-10, 2010 | 149 | 2010 |
| Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells I Perroteau, D Salomon, M DeBortoli, W Kidwell, P Hazarika, R Pardue, ... Breast cancer research and treatment 7, 201-210, 1986 | 141 | 1986 |
| Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues D Cimino, L Fuso, C Sfiligoi, N Biglia, R Ponzone, F Maggiorotto, G Russo, ... International journal of cancer 123 (6), 1327-1338, 2008 | 135 | 2008 |
| Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression C Bardella, B Costa, P Maggiora, S Patane’, M Olivero, GN Ranzani, ... Cancer research 64 (15), 5154-5161, 2004 | 125 | 2004 |
| Amplified expression of p21 ras protein in hormone-dependent mammary carcinomas of humans and rodents ME Debortoli, H Abou-Issa, BE Haley, YS Cho-Chung Biochemical and biophysical research communications 127 (2), 699-706, 1985 | 116 | 1985 |
| Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer. M Giai, R Roagna, R Ponzone, M De Bortoli, C Dati, P Sismondi Anticancer research 14 (3B), 1441-1450, 1994 | 114 | 1994 |
| A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome L Cicatiello, C Scafoglio, L Altucci, M Cancemi, G Natoli, A Facchiano, ... Journal of molecular endocrinology 32 (3), 719-775, 2004 | 108 | 2004 |
| c‐erbB‐2 and ras expression levels in breast cancer are correlated and show a co‐operative association with unfavorable clinical outcome C Dati, R Muraca, O Tazartes, S Antoniotti, I Perroteau, M Giai, P Cortese, ... International journal of cancer 47 (6), 833-838, 1991 | 100 | 1991 |
| Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays M Ravo, M Mutarelli, L Ferraro, OMV Grober, O Paris, R Tarallo, ... Laboratory Investigation 88 (4), 430-440, 2008 | 96 | 2008 |
| Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells L Caizzi, G Ferrero, S Cutrupi, F Cordero, C Ballaré, V Miano, S Reineri, ... Proceedings of the National Academy of Sciences 111 (13), 4892-4897, 2014 | 93 | 2014 |
| AP‐2α and AP‐2γ regulate tumor progression via specific genetic programs F Orso, E Penna, D Cimino, E Astanina, F Maione, D Valdembri, ... The FASEB Journal 22 (8), 2702-2714, 2008 | 85 | 2008 |
| Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitro S Antoniotti, P Maggiora, C Dati, M De Bortoli European Journal of Cancer 28 (2-3), 318-321, 1992 | 84 | 1992 |
| AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen V Perissi, N Menini, E Cottone, D Capello, M Sacco, F Montaldo, ... Oncogene 19 (2), 280-288, 2000 | 82 | 2000 |
| Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells A Courtin, L Communal, M Vilasco, D Cimino, N Mourra, M de Bortoli, ... Breast cancer research and treatment 131, 49-63, 2012 | 75 | 2012 |
| Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer R Orlandi, M De Bortoli, CM Ciniselli, E Vaghi, D Caccia, V Garrisi, ... Annals of oncology 25 (2), 352-357, 2014 | 71 | 2014 |
